Found: 1
Select item for more details and to access through your institution.
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 835, doi. 10.1111/dom.12472
- By:
- Publication type:
- Article